# Immunoscintigraphy Using Radiolabeled Monoclonal Antibody in Finding Tumor Cells in Patients With Colorectal Cancer

> **NCT00647153** · PHASE1 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **OTHER:** pharmacological study
- **PROCEDURE:** single photon emission computed tomography
- **RADIATION:** iodine I 123 anti-CEA recombinant diabody T84.66

## Key facts

- **NCT ID:** NCT00647153
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2017-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00647153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00647153, "Immunoscintigraphy Using Radiolabeled Monoclonal Antibody in Finding Tumor Cells in Patients With Colorectal Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00647153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*